Gastric acid-reducing medications and clopidogrel: What are the latest FDA recommendations

American Journal of Gastroenterology

Volumn 105, Issue 5, 2010, Pages 1211-

  Alkhatib, Amer A ^a   Elkhatib, Fateh A ^b   Khatib, Omar F ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CIMETIDINE; CLOPIDOGREL; ESOMEPRAZOLE; FAMOTIDINE; NIZATIDINE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ANTICOAGULATION; DRUG INFORMATION; FOOD AND DRUG ADMINISTRATION; LETTER; PRIORITY JOURNAL; STOMACH ACID;

ANTICOAGULANTS; DRUG INTERACTIONS; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HUMANS; MALE; OMEPRAZOLE; PROTON PUMP INHIBITORS; SAFETY MANAGEMENT; THROMBOEMBOLISM; TICLOPIDINE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77951954489     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.722     Document Type: Letter

References (2)

1. Kwok A, Faigel DO. Management of anticoagulation before and aft er gastrointestinal endoscopy. Am J Gastroenterol 2009; 104:3085-3097
2. http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsand-Providers/ DrugSafetyInformationforHeathcare-Professionals/ucm190787.htm Accessed on 21 November 2009.